Haizhu Chen

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Tyrosine Kinase

Systemic Lupus Erythematosus

Bioinformatics Analysis

Diffuse Large B Cell Lymphoma

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Ling Lin, Daquan Wang, Haizhu Chen
The characteristics and survival of second primary lung cancer after Hodgkin's lymphoma: A comparison with first primary lung cancer using the SEER database. PloS one 18 (5) (2023)
Ling Lin, Daquan Wang, Haizhu Chen
The characteristics and survival of second primary lung cancer after Hodgkin's lymphoma: A comparison with first primary lung cancer using the SEER database. PloS one 18 (5) (2023)
Liyuan Dai, Haizhu Chen, Qiaoyun Tan, Yanrong Wang, Lin Li, Ning Lou, Guangyu Fan, Tongji Xie, Rongrong Luo, Shasha Wang, Yu Zhou, Qiaofeng Zhong, Jiarui Yao, Zhishang Zhang, Le Tang, Yuan-Kai Shi, Xiao-Hong Han
Identification of novel prognostic autoantibodies in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone via a high-throughput antigen microarray. Cancer (2023)
Liyuan Dai, Haizhu Chen, Qiaoyun Tan, Yanrong Wang, Lin Li, Ning Lou, Guangyu Fan, Tongji Xie, Rongrong Luo, Shasha Wang, Yu Zhou, Qiaofeng Zhong, Jiarui Yao, Zhishang Zhang, Le Tang, Yuan-Kai Shi, Xiao-Hong Han
Identification of novel prognostic autoantibodies in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone via a high-throughput antigen microarray. Cancer 130 (8) (2023)
Ling Lin, Daquan Wang, Haizhu Chen
The characteristics and survival of second primary lung cancer after Hodgkin's lymphoma: A comparison with first primary lung cancer using the SEER database. PloS one 18 (5) (2023)
Liyuan Dai, Haizhu Chen, Qiaoyun Tan, Yanrong Wang, Lin Li, Ning Lou, Guangyu Fan, Tongji Xie, Rongrong Luo, Shasha Wang, Yu Zhou, Qiaofeng Zhong, Jiarui Yao, Zhishang Zhang, Le Tang, Yuan-Kai Shi, Xiao-Hong Han
Identification of novel prognostic autoantibodies in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone via a high-throughput antigen microarray. Cancer 130 (8) (2023)